title: Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study.
abstract: Inverse associations of coffee and/or tea in relation to hepatocellular carcinoma (HCC) risk have been consistently identified in studies conducted mostly in Asia where consumption patterns of such beverages differ from Europe. In the European Prospective Investigation into Cancer and nutrition (EPIC), we identified 201 HCC cases among 486,799 men/women, after a median follow-up of 11 years. We calculated adjusted hazard ratios (HRs) for HCC incidence in relation to quintiles/categories of coffee/tea intakes. We found that increased coffee and tea intakes were consistently associated with lower HCC risk. The inverse associations were substantial, monotonic and statistically significant. Coffee consumers in the highest compared to the lowest quintile had lower HCC risk by 72% [HR: 0.28; 95% confidence intervals (CIs): 0.16-0.50, p-trend < 0.001]. The corresponding association of tea with HCC risk was 0.41 (95% CI: 0.22-0.78, p-trend = 0.003). There was no compelling evidence of heterogeneity of these associations across strata of important HCC risk factors, including hepatitis B or hepatitis C status (available in a nested case-control study). The inverse, monotonic associations of coffee intake with HCC were apparent for caffeinated (p-trend = 0.009), but not decaffeinated (p-trend = 0.45) coffee for which, however, data were available for a fraction of subjects. Results from this multicentre, European cohort study strengthen the existing evidence regarding the inverse association between coffee/tea and HCC risk. Given the apparent lack of heterogeneity of these associations by HCC risk factors and that coffee/tea are universal exposures, our results could have important implications for high HCC risk subjects.
authors.affiliation: Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
authors.forename: Christina
authors.initials: C
authors.lastname: Bamia
authors.forename: Pagona
authors.initials: P
authors.lastname: Lagiou
authors.forename: Mazda
authors.initials: M
authors.lastname: Jenab
authors.forename: Antonia
authors.initials: A
authors.lastname: Trichopoulou
authors.forename: Veronika
authors.initials: V
authors.lastname: Fedirko
authors.forename: Krasimira
authors.initials: K
authors.lastname: Aleksandrova
authors.forename: Tobias
authors.initials: T
authors.lastname: Pischon
authors.forename: Kim
authors.initials: K
authors.lastname: Overvad
authors.forename: Anja
authors.initials: A
authors.lastname: Olsen
authors.forename: Anne
authors.initials: A
authors.lastname: Tjønneland
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Boutron-Ruault
authors.forename: Guy
authors.initials: G
authors.lastname: Fagherazzi
authors.forename: Antoine
authors.initials: A
authors.lastname: Racine
authors.forename: Tilman
authors.initials: T
authors.lastname: Kuhn
authors.forename: Heiner
authors.initials: H
authors.lastname: Boeing
authors.forename: Anna
authors.initials: A
authors.lastname: Floegel
authors.forename: Vasiliki
authors.initials: V
authors.lastname: Benetou
authors.forename: Domenico
authors.initials: D
authors.lastname: Palli
authors.forename: Sara
authors.initials: S
authors.lastname: Grioni
authors.forename: Salvatore
authors.initials: S
authors.lastname: Panico
authors.forename: Rosario
authors.initials: R
authors.lastname: Tumino
authors.forename: Paolo
authors.initials: P
authors.lastname: Vineis
authors.forename: H B
authors.initials: HB
authors.lastname: Bueno-de-Mesquita
authors.forename: Vincent K
authors.initials: VK
authors.lastname: Dik
authors.forename: Nirmala
authors.initials: N
authors.lastname: Bhoo-Pathy
authors.forename: Cuno S P M
authors.initials: CS
authors.lastname: Uiterwaal
authors.forename: Elisabete
authors.initials: E
authors.lastname: Weiderpass
authors.forename: Eiliv
authors.initials: E
authors.lastname: Lund
authors.forename: J Ramón
authors.initials: JR
authors.lastname: Quirós
authors.forename: Raul
authors.initials: R
authors.lastname: Zamora-Ros
authors.forename: Esther
authors.initials: E
authors.lastname: Molina-Montes
authors.forename: Maria-Dolores
authors.initials: MD
authors.lastname: Chirlaque
authors.forename: Eva
authors.initials: E
authors.lastname: Ardanaz
authors.forename: Miren
authors.initials: M
authors.lastname: Dorronsoro
authors.forename: Björn
authors.initials: B
authors.lastname: Lindkvist
authors.forename: Peter
authors.initials: P
authors.lastname: Wallström
authors.forename: Lena Maria
authors.initials: LM
authors.lastname: Nilsson
authors.forename: Malin
authors.initials: M
authors.lastname: Sund
authors.forename: Kay-Tee
authors.initials: KT
authors.lastname: Khaw
authors.forename: Nick
authors.initials: N
authors.lastname: Wareham
authors.forename: Kathryn E
authors.initials: KE
authors.lastname: Bradbury
authors.forename: Ruth C
authors.initials: RC
authors.lastname: Travis
authors.forename: Pietro
authors.initials: P
authors.lastname: Ferrari
authors.forename: Talita
authors.initials: T
authors.lastname: Duarte-Salles
authors.forename: Magdalena
authors.initials: M
authors.lastname: Stepien
authors.forename: Marc
authors.initials: M
authors.lastname: Gunter
authors.forename: Neil
authors.initials: N
authors.lastname: Murphy
authors.forename: Elio
authors.initials: E
authors.lastname: Riboli
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Trichopoulos
mesh_terms: D001628:Beverages / Q000009:adverse effects; D002110:Caffeine / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology* / Q000209:etiology*; D016022:Case-Control Studies; D003069:Coffee / Q000009:adverse effects*; D005060:Europe; D005260:Female; D006801:Humans; D015994:Incidence; D008113:Liver Neoplasms / Q000453:epidemiology* / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012306:Risk; D018570:Risk Assessment; D012307:Risk Factors; D013662:Tea / Q000009:adverse effects*
chemical_list: D003069:Coffee; D013662:Tea; D002110:Caffeine
keywords: EPIC; coffee; hepatocellular carcinoma; liver cancer; tea